150 related articles for article (PubMed ID: 14965378)
1. Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease.
Serafini M; Manganini M; Borleri G; Bonamino M; Imberti L; Biondi A; Golay J; Rambaldi A; Introna M
Hum Gene Ther; 2004 Jan; 15(1):63-76. PubMed ID: 14965378
[TBL] [Abstract][Full Text] [Related]
2. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
3. Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies.
Introna M; Barbui AM; Bambacioni F; Casati C; Gaipa G; Borleri G; Bernasconi S; Barbui T; Golay J; Biondi A; Rambaldi A
Hum Gene Ther; 2000 Mar; 11(4):611-20. PubMed ID: 10724039
[TBL] [Abstract][Full Text] [Related]
4. The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells.
van Meerten T; Claessen MJ; Hagenbeek A; Ebeling SB
Gene Ther; 2006 May; 13(9):789-97. PubMed ID: 16421601
[TBL] [Abstract][Full Text] [Related]
5. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus mediated gene transduction of human T-cell subsets.
Hedfors IA; Beckstrøm KJ; Benati C; Bonini C; Brinchmann JE
Cancer Immunol Immunother; 2005 Aug; 54(8):759-68. PubMed ID: 15655695
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
[TBL] [Abstract][Full Text] [Related]
8. Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.
Watanabe K; Terakura S; Martens AC; van Meerten T; Uchiyama S; Imai M; Sakemura R; Goto T; Hanajiri R; Imahashi N; Shimada K; Tomita A; Kiyoi H; Nishida T; Naoe T; Murata M
J Immunol; 2015 Feb; 194(3):911-20. PubMed ID: 25520398
[TBL] [Abstract][Full Text] [Related]
9. Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy.
Griffioen M; van Egmond EH; Kester MG; Willemze R; Falkenburg JH; Heemskerk MH
Haematologica; 2009 Sep; 94(9):1316-20. PubMed ID: 19734426
[TBL] [Abstract][Full Text] [Related]
10. T cells for suicide gene therapy: activation, functionality and clinical relevance.
Hollatz G; Grez M; Mastaglio S; Quaritsch R; Huenecke S; Ciceri F; Bonini C; Esser R; Klingebiel T; Kreuter J; Koehl U
J Immunol Methods; 2008 Feb; 331(1-2):69-81. PubMed ID: 18155021
[TBL] [Abstract][Full Text] [Related]
11. CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
Bonifant CL; Szoor A; Torres D; Joseph N; Velasquez MP; Iwahori K; Gaikwad A; Nguyen P; Arber C; Song XT; Redell M; Gottschalk S
Mol Ther; 2016 Sep; 24(9):1615-26. PubMed ID: 27401038
[TBL] [Abstract][Full Text] [Related]
12. Preparation of genetically homogeneous antigen-specific thymidine kinase positive T-lymphocyte clones for the control of alloreactivity post-bone marrow transplantation.
Clémenceau B; Gallot G; Lemoine FM; Klatzmann D; Vié H
Hum Gene Ther; 2004 Jun; 15(6):542-52. PubMed ID: 15212713
[TBL] [Abstract][Full Text] [Related]
13. beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction.
Di Ianni M; Casciari C; Ciurnelli R; Fulvi A; Bagnis C; Lucheroni F; Falzetti F; Mannoni P; Martelli MF; Tabilio A
Haematologica; 1996; 81(5):410-7. PubMed ID: 8952153
[TBL] [Abstract][Full Text] [Related]
14. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.
Robinet E; Fehse B; Ebeling S; Sauce D; Ferrand C; Tiberghien P
Cytotherapy; 2005; 7(2):150-7. PubMed ID: 16040394
[TBL] [Abstract][Full Text] [Related]
15. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
Karakhanova S; Munder M; Schneider M; Bonyhadi M; Ho AD; Goerner M
J Immunother; 2006; 29(3):336-49. PubMed ID: 16699377
[TBL] [Abstract][Full Text] [Related]
16. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.
Lemoine FM; Mesel-Lemoine M; Cherai M; Gallot G; Vié H; Leclercq V; Trébèden-Negre H; Mammès O; Boyer O; Noguiez-Hellin P; Klatzmann D
J Gene Med; 2004 Apr; 6(4):374-86. PubMed ID: 15079812
[TBL] [Abstract][Full Text] [Related]
17. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells.
Coito S; Sauce D; Duperrier A; Certoux JM; Bonyhadi M; Collette A; Kuehlcke K; Hervé P; Tiberghien P; Robinet E; Ferrand C
Stem Cells Dev; 2004 Feb; 13(1):71-81. PubMed ID: 15068695
[TBL] [Abstract][Full Text] [Related]
19. Suicide gene therapy for graft-versus-host disease.
Georgoudaki AM; Sutlu T; Alici E
Immunotherapy; 2010 Jul; 2(4):521-37. PubMed ID: 20636006
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHD.
Mailly L; Leboeuf C; Tiberghien P; Baumert T; Robinet E
Curr Opin Investig Drugs; 2010 May; 11(5):559-70. PubMed ID: 20419602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
